AAAAAA
Results: 26-50/282
Authors:
DEKROON JFEM
VANBERGEN CAM
DEPAUS RA
KLUINNELEMANS HC
WILLEMZE R
FALKENBURG JHF
Citation: Jfem. Dekroon et al., HUMAN CYTOTOXIC CD8(-LYMPHOCYTE CLONES ENGRAFT IN SEVERE COMBINED IMMUNODEFICIENT (SCID) MICE BUT SHOW DIMINISHED FUNCTION() T), Journal of immunotherapy with emphasis on tumor immunology, 20(2), 1997, pp. 101-110
Authors:
FU EJ
ARCA MJ
HAIN JM
KRINOCK R
RADO J
CAMERON MJ
CHANG AE
SONDAK VK
Citation: Ej. Fu et al., TUMOR-INDUCED SUPPRESSION OF ANTITUMOR REACTIVITY AND DEPRESSION OF TCR-ZETA EXPRESSION IN TUMOR-DRAINING LYMPH-NODE LYMPHOCYTES - POSSIBLERELATIONSHIP TO THE TH2 PATHWAY, Journal of immunotherapy with emphasis on tumor immunology, 20(2), 1997, pp. 111-122
Authors:
LI YQ
KOBAYASHI M
KURAMITSU Y
YUAN L
MATSUSHITA K
YAGITA H
OKUMURA K
HOSOKAWA M
Citation: Yq. Li et al., ENHANCEMENT OF LYMPHOKINE-ACTIVATED KILLER-CELL ACTIVITY BY FIBRONECTIN, Journal of immunotherapy with emphasis on tumor immunology, 20(2), 1997, pp. 123-130
Authors:
GELLER RL
NEUENFELDT S
LEVON SA
MARYANOV DA
THOMAS TJ
BRAUKER JH
Citation: Rl. Geller et al., IMMUNOISOLATION OF TUMOR-CELLS - GENERATION OF ANTITUMOR IMMUNITY THROUGH INDIRECT PRESENTATION OF ANTIGEN, Journal of immunotherapy with emphasis on tumor immunology, 20(2), 1997, pp. 131-137
Authors:
ARCA MJ
KRAUSS JC
ARUGA A
CAMERON MJ
CHANG AE
Citation: Mj. Arca et al., CONCURRENT INDUCTION OF CD4(-CELLS DURING TUMOR-GROWTH WITH ANTITUMORREACTIVITY IN ADOPTIVE IMMUNOTHERAPY() AND CD8(+) T), Journal of immunotherapy with emphasis on tumor immunology, 20(2), 1997, pp. 138-145
Authors:
KIRKWOOD JM
BRYANT J
SCHILLER JH
OKEN MM
BORDEN EC
WHITESIDE TL
Citation: Jm. Kirkwood et al., IMMUNOMODULATORY FUNCTION OF INTERFERON-GAMMA IN PATIENTS WITH METASTATIC MELANOMA - RESULTS OF A PHASE II-B TRIAL IN SUBJECTS WITH METASTATIC MELANOMA, ECOG STUDY E-4987, Journal of immunotherapy with emphasis on tumor immunology, 20(2), 1997, pp. 146-157
Authors:
FERLAZZO G
SCISCA C
IEMMO R
CAVALIERE R
QUARTARONE G
ADAMO V
FRAZZETTO G
COSTA G
MELIOLI G
Citation: G. Ferlazzo et al., INTRALESIONAL SONOGRAPHICALLY GUIDED INJECTIONS OF LYMPHOKINE-ACTIVATED KILLER-CELLS AND RECOMBINANT INTERLEUKIN-2 FOR THE TREATMENT OF LIVER-TUMORS - A PILOT-STUDY, Journal of immunotherapy with emphasis on tumor immunology, 20(2), 1997, pp. 158-163
Authors:
SALGALLER ML
Citation: Ml. Salgaller, MONITORING OF CANCER-PATIENTS UNDERGOING ACTIVE OR PASSIVE IMMUNOTHERAPY, Journal of immunotherapy with emphasis on tumor immunology, 20(1), 1997, pp. 1-14
Authors:
ZHAI YF
YANG JC
SPIESS P
NISHIMURA MI
OVERWIJK WW
ROBERTS B
RESTIFO NP
ROSENBERG SA
Citation: Yf. Zhai et al., CLONING AND CHARACTERIZATION OF THE GENES ENCODING THE MURINE HOMOLOGS OF THE HUMAN-MELANOMA ANTIGENS MART1 AND GP100, Journal of immunotherapy with emphasis on tumor immunology, 20(1), 1997, pp. 15-25
Authors:
CLARY BM
COVENEY EC
BLAZER DG
PHILIP R
PHILIP M
MORSE M
GILBOA E
LYERLY HK
Citation: Bm. Clary et al., ACTIVE IMMUNIZATION WITH TUMOR-CELLS TRANSDUCED BY A NOVEL AAV PLASMID-BASED GENE DELIVERY SYSTEM, Journal of immunotherapy with emphasis on tumor immunology, 20(1), 1997, pp. 26-37
Authors:
AKAGI J
HODGE JW
MCLAUGHLIN JP
GRITZ L
MAZZARA G
KUFE D
SCHLOM J
KANTOR JA
Citation: J. Akagi et al., THERAPEUTIC ANTITUMOR RESPONSE AFTER IMMUNIZATION WITH AN ADMIXTURE OF RECOMBINANT VACCINIA VIRUSES EXPRESSING A MODIFIED MUC1 GENE AND THEMURINE T-CELL COSTIMULATORY MOLECULE B7, Journal of immunotherapy with emphasis on tumor immunology, 20(1), 1997, pp. 38-47
Authors:
ABRAMS SI
HODGE JW
MCLAUGHLIN JP
STEINBERG SM
KANTOR JA
SCHLOM J
Citation: Si. Abrams et al., ADOPTIVE IMMUNOTHERAPY AS AN IN-VIVO MODEL TO EXPLORE ANTITUMOR MECHANISMS INDUCED BY A RECOMBINANT ANTICANCER VACCINE, Journal of immunotherapy with emphasis on tumor immunology, 20(1), 1997, pp. 48-59
Authors:
FETSCH PA
CORMIER J
HIJAZI YM
Citation: Pa. Fetsch et al., IMMUNOCYTOCHEMICAL DETECTION OF MART-1 IN FRESH AND PARAFFIN-EMBEDDEDMALIGNANT MELANOMAS, Journal of immunotherapy with emphasis on tumor immunology, 20(1), 1997, pp. 60-64
Authors:
UEDA H
YAMAZAKI M
Citation: H. Ueda et M. Yamazaki, INDUCTION OF TUMOR-NECROSIS-FACTOR IN A MURINE TUMOR BY SYSTEMIC ADMINISTRATION OF A NOVEL SYNTHETIC LIPID-A ANALOG, ONO-4007, Journal of immunotherapy with emphasis on tumor immunology, 20(1), 1997, pp. 65-69
Authors:
MACLEAN GD
REDDISH MA
LONGENECKER BM
Citation: Gd. Maclean et al., PROGNOSTIC-SIGNIFICANCE OF PREIMMUNOTHERAPY SERUM CA27.29 (MUC-1) MUCIN LEVEL AFTER ACTIVE SPECIFIC IMMUNOTHERAPY OF METASTATIC ADENOCARCINOMA PATIENTS, Journal of immunotherapy with emphasis on tumor immunology, 20(1), 1997, pp. 70-78
Authors:
REDDY SP
HARWOOD RM
MOORE DF
GRIMM EA
MURRAY JL
VADHANRAJ S
Citation: Sp. Reddy et al., RECOMBINANT INTERLEUKIN-2 IN COMBINATION WITH RECOMBINANT INTERFERON-GAMMA IN PATIENTS WITH ADVANCED MALIGNANCY - A PHASE-1 STUDY, Journal of immunotherapy with emphasis on tumor immunology, 20(1), 1997, pp. 79-87
Authors:
BRADY MS
ECKELS DD
REE SY
SCHULTHEISS KE
LEE JS
Citation: Ms. Brady et al., MHC CLASS II-MEDIATED ANTIGEN PRESENTATION BY MELANOMA-CELLS, Journal of immunotherapy with emphasis on tumor immunology, 19(6), 1996, pp. 387-397
Authors:
AKPORIAYE ET
PANELLI MC
Citation: Et. Akporiaye et Mc. Panelli, FUNCTIONAL CLASS-II ANTIGEN PRESENTATION PATHWAY IN METASTATIC MELANOMA CELL-LINES, Journal of immunotherapy with emphasis on tumor immunology, 19(6), 1996, pp. 398-398
Authors:
MIYAJIMA J
IMAI Y
NAKAO M
NODA S
ITOH K
Citation: J. Miyajima et al., HIGHER SUSCEPTIBILITY OF ERYTHROPOIETIN-PRODUCING RENAL-CELL CARCINOMAS TO LYSIS BY LYMPHOKINE-ACTIVATED KILLER-CELLS, Journal of immunotherapy with emphasis on tumor immunology, 19(6), 1996, pp. 399-404
Authors:
THOMPSON RC
PARDOLL DM
JAFFEE EM
EWEND MG
THOMAS MC
TYLER BM
BREM H
Citation: Rc. Thompson et al., SYSTEMIC AND LOCAL PARACRINE CYTOKINE THERAPIES USING TRANSDUCED TUMOR-CELLS ARE SYNERGISTIC IN TREATING INTRACRANIAL TUMORS, Journal of immunotherapy with emphasis on tumor immunology, 19(6), 1996, pp. 405-413
Authors:
GABRILOVICH DI
CUNNINGHAM HT
CARBONE DP
Citation: Di. Gabrilovich et al., IL-12 AND MUTANT P53 PEPTIDE-PULSED DENDRITIC CELLS FOR THE SPECIFIC IMMUNOTHERAPY OF CANCER, Journal of immunotherapy with emphasis on tumor immunology, 19(6), 1996, pp. 414-418
Authors:
PREWETT M
ROCKWELL P
ROCKWELL RF
GIORGIO NA
MENDELSOHN J
SCHER HI
GOLDSTEIN NI
Citation: M. Prewett et al., THE BIOLOGIC EFFECTS OF C225, A CHIMERIC MONOCLONAL-ANTIBODY TO THE EGFR, ON HUMAN PROSTATE CARCINOMA, Journal of immunotherapy with emphasis on tumor immunology, 19(6), 1996, pp. 419-427
Authors:
KAGESHITA T
NARUSE T
HIRAI S
HORIKOSHI T
NAKAGAWA H
TAMAKI K
HAYASHIBE K
ICHIHASHI M
NAKAYAMA J
HORI Y
OZAWA A
MIYAHARA M
OHKIDO M
INOKO H
ONO T
Citation: T. Kageshita et al., HLA CLASS-I ANTIGENS IN JAPANESE PATIENTS WITH MELANOMA, Journal of immunotherapy with emphasis on tumor immunology, 19(6), 1996, pp. 428-432
Authors:
VLOCK DR
ANDERSEN J
KALISH LA
JOHNSON JT
KIRKWOOD JM
WHITESIDE T
HERBERMAN RB
ADAMS GS
OKEN MM
HASELOW RE
Citation: Dr. Vlock et al., PHASE-II TRIAL OF INTERFERON-ALPHA IN LOCALLY RECURRENT OR METASTATICSQUAMOUS-CELL CARCINOMA OF THE HEAD AND NECK - IMMUNOLOGICAL AND CLINICAL CORRELATES, Journal of immunotherapy with emphasis on tumor immunology, 19(6), 1996, pp. 433-442
Authors:
FREEDMAN RS
GIBBONS JA
GIEDLIN M
KUDELKA AP
KAVANAGH JJ
EDWARDS CL
CARRASCO CH
NASH MA
PLATSOUCAS CD
Citation: Rs. Freedman et al., IMMUNOPHARMACOLOGY AND CYTOKINE PRODUCTION OF A LOW-DOSE SCHEDULE OF INTRAPERITONEALLY ADMINISTERED HUMAN RECOMBINANT INTERLEUKIN-2 IN PATIENTS WITH ADVANCED EPITHELIAL OVARIAN-CARCINOMA, Journal of immunotherapy with emphasis on tumor immunology, 19(6), 1996, pp. 443-451